Neurocritical Care

, Volume 17, Supplement 1, pp 37–46

Emergency Neurological Life Support: Intracerebral Hemorrhage

  • Charles M. Andrews
  • Edward C. Jauch
  • J. Claude HemphillIII
  • Wade S. Smith
  • Scott D. Weingart
Review Article

Abstract

Intracerebral hemorrhage (ICH) is a subset of stroke resulting from bleeding within the brain parenchyma of the brain. It is potentially lethal, and survival depends on ensuring an adequate airway, reversal of coagulopathy, and proper diagnosis. ICH was chosen as an emergency neurological life support (ENLS) protocol because intervention within the first critical hour may improve outcome, and it is helpful to have a protocol to drive care quickly and efficiently.

Keywords:

Hypertensive hemorrhage Secondary brain injury Coagulopathy Protocol 

References

  1. 1.
    Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41:2108–29.CrossRefPubMedGoogle Scholar
  2. 2.
    European Stroke Initiative Writing C, Writing Committee for the EEC, Steiner T, et al. Recommendations for the management of intracranial haemorrhage—part I: spontaneous intracerebral haemorrhage. The European Stroke Initiative Writing Committee and the Writing Committee for the EUSI Executive Committee. Cerebrovasc Dis. 2006;22:294–316.Google Scholar
  3. 3.
    Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369:293–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Fiebach JB, Schellinger PD, Gass A, et al. Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke. 2004;35:502–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Kothari RU, Brott T, Broderick JP, et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke. 1996;27:1304–5.CrossRefPubMedGoogle Scholar
  6. 6.
    Brott T, Broderick J, Kothari R, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke. 1997;28:1–5.CrossRefPubMedGoogle Scholar
  7. 7.
    Goldstein JN, Fazen LE, Snider R, et al. Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. Neurology. 2007;68:889–94.CrossRefPubMedGoogle Scholar
  8. 8.
    Kim J, Smith A, Hemphill JC 3rd, et al. Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol. 2008;29:520–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Wada R, Aviv RI, Fox AJ, et al. CT angiography “spot sign” predicts hematoma expansion in acute intracerebral hemorrhage. Stroke. 2007;38:1257–62.CrossRefPubMedGoogle Scholar
  10. 10.
    Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Hemphill JC 3rd, Farrant M, Neill TA Jr. Prospective validation of the ICH Score for 12-month functional outcome. Neurology. 2009;73:1088–94.CrossRefPubMedGoogle Scholar
  12. 12.
    Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke. 1993;24:987–93.CrossRefPubMedGoogle Scholar
  13. 13.
    Rost NS, Smith EE, Chang Y, et al. Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke. 2008;39:2304–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Validation and comparison of models predicting survival following intracerebral hemorrhage. Crit Care Med. 1995;23:950–4.CrossRefPubMedGoogle Scholar
  15. 15.
    Hemphill JC 3rd, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004;35:1130–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Hemphill JC 3rd, White DB. Clinical nihilism in neuroemergencies. Emerg Med Clin North Am. 2009;27:27–37. vii-viii.CrossRefPubMedGoogle Scholar
  17. 17.
    Davis SM, Broderick J, Hennerici M, et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology. 2006;66:1175–81.CrossRefPubMedGoogle Scholar
  18. 18.
    Flibotte JJ, Hagan N, O’Donnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology. 2004;63:1059–64.CrossRefPubMedGoogle Scholar
  19. 19.
    Jauch EC, Lindsell CJ, Adeoye O, et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061–5.CrossRefPubMedGoogle Scholar
  20. 20.
    Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke. 1997;28:2370–5.CrossRefPubMedGoogle Scholar
  21. 21.
    Qureshi AI, Wilson DA, Hanley DF, Traystman RJ. No evidence for an ischemic penumbra in massive experimental intracerebral hemorrhage. Neurology. 1999;52:266–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804–10.CrossRefPubMedGoogle Scholar
  23. 23.
    Antihypertensive Treatment of Acute Cerebral Hemorrhage Investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med. 2010;38:637–48.CrossRefGoogle Scholar
  24. 24.
    Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7:391–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Hanley JP. Warfarin reversal. J Clin Pathol. 2004;57:1132–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Huttner HB, Schellinger PD, Hartmann M, et al. Hematoma growth and outcome in treated neurocritical care patients with intracerebral hemorrhage related to oral anticoagulant therapy: comparison of acute treatment strategies using vitamin K, fresh frozen plasma, and prothrombin complex concentrates. Stroke. 2006;37:1465–70.CrossRefPubMedGoogle Scholar
  27. 27.
    Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:204S–33S.CrossRefPubMedGoogle Scholar
  28. 28.
    Guidelines on oral anticoagulation: third edition. Br J Haematol. 1998;101:374–87.Google Scholar
  29. 29.
    Schulman S. Clinical practice. Care of patients receiving long-term anticoagulant therapy. N Engl J Med. 2003;349:675–83.CrossRefPubMedGoogle Scholar
  30. 30.
    Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127–37.CrossRefPubMedGoogle Scholar
  31. 31.
    Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke. 2006;37:2165–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Naidech AM, Bernstein RA, Levasseur K, et al. Platelet activity and outcome after intracerebral hemorrhage. Ann Neurol. 2009;65:352–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Sansing LH, Messe SR, Cucchiara BL, et al. Prior antiplatelet use does not affect hemorrhage growth or outcome after ICH. Neurology. 2009;72:1397–402.CrossRefPubMedGoogle Scholar
  34. 34.
    Thompson BB, Bejot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75:1333–42.CrossRefPubMedGoogle Scholar
  35. 35.
    Toyoda K, Okada Y, Minematsu K, et al. Antiplatelet therapy contributes to acute deterioration of intracerebral hemorrhage. Neurology. 2005;65:1000–4.CrossRefPubMedGoogle Scholar
  36. 36.
    Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124:1573–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Oh JJ, Akers WS, Lewis D, Ramaiah C, Flynn JD. Recombinant factor VIIa for refractory bleeding after cardiac surgery secondary to anticoagulation with the direct thrombin inhibitor lepirudin. Pharmacotherapy. 2006;26:569–77.CrossRefPubMedGoogle Scholar
  38. 38.
    Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med Rev. 2007;21:37–48.CrossRefPubMedGoogle Scholar
  39. 39.
    Mendelow AD, Gregson BA, Fernandes HM, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387–97.PubMedGoogle Scholar
  40. 40.
    Auer LM, Deinsberger W, Niederkorn K, et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg. 1989;70:530–5.CrossRefPubMedGoogle Scholar
  41. 41.
    Niizuma H, Shimizu Y, Yonemitsu T, Nakasato N, Suzuki J. Results of stereotactic aspiration in 175 cases of putaminal hemorrhage. Neurosurgery. 1989;24:814–9.CrossRefPubMedGoogle Scholar
  42. 42.
    Vespa P, McArthur D, Miller C, et al. Frameless stereotactic aspiration and thrombolysis of deep intracerebral hemorrhage is associated with reduction of hemorrhage volume and neurological improvement. Neurocrit Care. 2005;2:274–81.CrossRefPubMedGoogle Scholar
  43. 43.
    Firsching R, Huber M, Frowein RA. Cerebellar haemorrhage: management and prognosis. Neurosurg Rev. 1991;14:191–4.CrossRefPubMedGoogle Scholar
  44. 44.
    Kirollos RW, Tyagi AK, Ross SA, van Hille PT, Marks PV. Management of spontaneous cerebellar hematomas: a prospective treatment protocol. Neurosurgery. 2001;49:1378–86. Discussion: 86–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29:635–40.CrossRefPubMedGoogle Scholar
  46. 46.
    Schwarz S, Hafner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54:354–61.CrossRefPubMedGoogle Scholar
  47. 47.
    Vespa PM. Intensive glycemic control in traumatic brain injury: what is the ideal glucose range? Crit Care. 2008;12:175.CrossRefPubMedGoogle Scholar
  48. 48.
    Chambers IR, Banister K, Mendelow AD. Intracranial pressure within a developing intracerebral haemorrhage. Br J Neurosurg. 2001;15:140–1.CrossRefPubMedGoogle Scholar
  49. 49.
    Fernandes HM, Siddique S, Banister K, et al. Continuous monitoring of ICP and CPP following ICH and its relationship to clinical, radiological and surgical parameters. Acta Neurochir Suppl. 2000;76:463–6.PubMedGoogle Scholar
  50. 50.
    Ziai WC, Torbey MT, Naff NJ, et al. Frequency of sustained intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Cerebrovasc Dis. 2009;27:403–10.CrossRefPubMedGoogle Scholar
  51. 51.
    De Herdt V, Dumont F, Hénon H, et al. Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology. 2011;77:1794–800.CrossRefPubMedGoogle Scholar
  52. 52.
    Passero S, Rocchi R, Rossi S, Ulivelli M, Vatti G. Seizures after spontaneous supratentorial intracerebral hemorrhage. Epilepsia. 2002;43:1175–80.CrossRefPubMedGoogle Scholar
  53. 53.
    Messe SR, Sansing LH, Cucchiara BL, et al. Prophylactic antiepileptic drug use is associated with poor outcome following ICH. Neurocrit Care. 2009;11:38–44.CrossRefPubMedGoogle Scholar
  54. 54.
    Naidech AM, Garg RK, Liebling S, et al. Anticonvulsant use and outcomes after intracerebral hemorrhage. Stroke. 2009;40:3810–5.CrossRefPubMedGoogle Scholar
  55. 55.
    Claassen J, Jette N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology. 2007;69:1356–65.CrossRefPubMedGoogle Scholar
  56. 56.
    Vespa PM, O’Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology. 2003;60:1441–6.CrossRefPubMedGoogle Scholar

Copyright information

© Neurocritical Care Society 2012

Authors and Affiliations

  • Charles M. Andrews
    • 1
  • Edward C. Jauch
    • 2
  • J. Claude HemphillIII
    • 3
  • Wade S. Smith
    • 3
  • Scott D. Weingart
    • 4
  1. 1.Department of NeurosciencesMedical University of South CarolinaCharlestonUSA
  2. 2.Division of Emergency Medicine and Department of NeurosciencesMedical University of South CarolinaCharlestonUSA
  3. 3.ENLS Course Co-Chair, Department of NeurologyUniversity of CaliforniaSan FranciscoUSA
  4. 4.ENLS Course Co-Chair, Division of ED Critical CareMount Sinai School of MedicineNew YorkUSA

Personalised recommendations